Inventor · disambiguated record
Tomas Rouse
Also filed as: ROUSE TOMAS
0 granted patents·6 pending applications·0 citations·filing 2022–2024
Files withASTRAZENECA AB6
Top patents by PatentIndex Score
6 records- 0173US2024400699A1Anti-ifnar1 dosing regime for subcutaneous injectionASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0272US2024360231A1DoseASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0365US2022340669A1DoseASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 0461US2025002590A1Treatment of lupus nephritis with anti-type i inf receptor antibody anifrolumabASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 0561US2022348669A1Treatment of lupus nephritisASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 0657US2025002589A1Treatment of cutaneous lupus erythematousASTRAZENECA AB·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tomas Rouse files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →